Advertisement
Intas Pharma
Healthcare
11 October, 2022
CCI clears Adia investment in Intas Pharmaceuticals
The Competition Commission of India on Monday approved Singapore’s state investment arm Temasek’s move to sell a 3% stake in ......
The Competition Commission of India on Monday approved Singapore’s state investment arm Temasek’s move to sell a 3% stake in ......